 |
|
Old Drugs for a New Bug
Influenza, HIV Drugs Enlisted to Fight SARS
Brian Vastag
JAMA. 2003;290:1695-1696.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In the span of a season, a global cadre of researchers has leveraged years of drug development into a slew of possible treatments for severe acute respiratory syndrome (SARS). Since the beginning of the SARS outbreak last spring, large drug companies have dusted off libraries of failed antivirals, famous researchers have adapted the latest anti-HIV strategy, and federal agencies have busied themselves screening thousands of existing drugs.
| |
Researchers are exploring a variety of possible agents to treat individuals infected with the SARS-associated coronavirus. N Engl J Med. 2003;348:1953-1966. (Photo credit: © Massachusetts Medical Society)
|
|
While the World Health Organization (WHO) stopped tracking SARS cases earlier this summer, the agency warns that the disease may simply be napping. Federal agencies, led by the National Institute of Allergy and Infectious Diseases (NIAID), agree and are backing work on anti-SARS drugs.
COVERING THE BASES
"Everybody here is very concerned about reemergence," . . . [Full Text of this Article]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
Yeh et al.
J Antimicrob Chemother 2005;56:919-922.
ABSTRACT
| FULL TEXT
Genetic Screen for Monitoring Severe Acute Respiratory Syndrome Coronavirus 3C-Like Protease
Parera et al.
J. Virol. 2004;78:14057-14061.
ABSTRACT
| FULL TEXT
|
